AKR1C3 Overexpression May Serve as a Promising Biomarker for Prostate Cancer Progression

Diagnostic Pathology - United Kingdom
doi 10.1186/1746-1596-9-42
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Fibroblast Growth Factor-23 May Serve as a Novel Biomarker for Renal Osteodystrophy Progression

International Journal of Molecular Medicine
MedicineGenetics
2018English

DKC1 Overexpression Associated With Prostate Cancer Progression

British Journal of Cancer
Cancer ResearchOncology
2009English

Nuclear iASPP May Facilitate Prostate Cancer Progression

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

Osteopontin -- A Promising Biomarker for Cancer Therapy

Journal of Cancer
Oncology
2017English

Lipidomics: A Promising Cancer Biomarker

Clinical and Translational Medicine
MedicineMolecular Medicine
2018English

Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification

Diagnostics
Clinical Biochemistry
2018English

Carbonic Anhydrase I as a New Plasma Biomarker for Prostate Cancer

ISRN Oncology
2012English

HMGB1: A Promising Therapeutic Target for Prostate Cancer

Prostate Cancer
Cancer ResearchOncologyUrology
2013English

Extracellular Vesicle DNA: A Promising Cancer Biomarker

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy